Fujifilm has declared its intention to sue Xerox for damages, saying the latter had “no legal right” to unilaterally pull out of the planned merger deal, reported Bloomberg.
Fujifilm plans to file a lawsuit as soon as possible, President Kenji Sukeno said Friday, May 18, in his first public comments days after the American office products company called off the deal in a settlement with activist shareholders Carl Icahn and Darwin Deason. Still, Fujifilm would also consider any new offer from Xerox, Sukeno said.
“The contract that ties the two companies together is still valid,” Sukeno said at a briefing in Tokyo to announce the company’s financial results. “We will push for the legality of it. There was a legal contract that everyone agreed on, and after that a few shareholders wanted to put a stop to it.”
Fujifilm last week disputed Xerox’s “unilateral decision” to scrap a plan for the Japanese company to take control of the once-iconic American office equipment supplier. Icahn and Deason, two of the biggest shareholders who argued the deal undervalued Xerox, succeeded in their bid to stymie the transaction and push out the American company’s chief executive officer.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Extends Support for Farms and Fisheries Amid Market Disruptions
May 5, 2024 by
CPI
Sony and Apollo Bid $26 Billion for Paramount Acquisition
May 5, 2024 by
CPI
Goldman Sachs Resolves Decade-Old Metal-Rigging Class Action Lawsuit
May 5, 2024 by
CPI
Italian Antitrust Ruling Puts Halt on Intesa Sanpaolo’s Fintech Ambitions
May 5, 2024 by
CPI
Google Antitrust Case: Closing Arguments Conclude
May 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI